William Blair & Company’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,711
Closed -$237K 1860
2023
Q1
$237K Sell
3,711
-1,208
-25% -$78.8K ﹤0.01% 1331
2022
Q4
$239K Hold
4,919
﹤0.01% 1309
2022
Q3
$347K Sell
4,919
-3,587
-42% -$307K ﹤0.01% 1171
2022
Q2
$603K Sell
8,506
-200
-2% -$12.9K ﹤0.01% 1005
2022
Q1
$696K Buy
8,706
+3,574
+70% +$266K ﹤0.01% 1045
2021
Q4
$469K Buy
5,132
+1,882
+58% +$202K ﹤0.01% 1235
2021
Q3
$418K Sell
3,250
-380
-10% -$53.2K ﹤0.01% 1221
2021
Q2
$554K Buy
3,630
+750
+26% +$98.8K ﹤0.01% 1119
2021
Q1
$304K Sell
2,880
-1,430
-33% -$143K ﹤0.01% 1327
2020
Q4
$341K Buy
+4,310
New +$315K ﹤0.01% 1211

Other funds holding STAA

William Blair & Company's STAA Position: Q2 2023 in Review

William Blair & Company sold out of STAAR Surgical (STAA) in Q2 2023, closing a stake of 3,711 shares — an estimated $237K sold.

William Blair & Company first reported a position in STAA in Q4 2020 and held it in 10 quarters. The position peaked at $696K in Q1 2022. 245 funds tracked by Wall St. Rank hold STAA as of Q2 2023.

  • William Blair & Company reported no remaining STAAR Surgical position as of Q2 2023 after selling out during the quarter.
  • William Blair & Company sold 3,711 STAAR Surgical shares in Q2 2023, an estimated $237K.
  • William Blair & Company first reported a position in STAAR Surgical in Q4 2020 and held it in 10 quarters.
  • William Blair & Company's STAAR Surgical position peaked at $696K in Q1 2022.
  • 245 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2023.

Based on William Blair & Company's 13F filing for Q2 2023, filed 11 Aug 2023.